| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $82K | +203.7% |
| Cost of Revenue | $32K | +39.1% |
| Gross Profit | $50K | +1150.0% |
| R&D Expense | $5.1M | -8.0% |
| SG&A Expense | $6.3M | +22.2% |
| Operating Income | -$10.5M | -4.7% |
| Pre-tax Income | -$10.3M | -21.5% |
| Income Tax | $1K | — |
| Net Income | -$10.3M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.1M | -19.2% |
| Accounts Receivable | $268K | +0.0% |
| Current Assets | $8.5M | -19.2% |
| Total Assets | $8.9M | -21.0% |
| Current Liabilities | $2.3M | +29.4% |
| Total Liabilities | $2.3M | -26.8% |
| Stockholders' Equity | $6.6M | -18.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.1M | -0.7% |
| Capital Expenditures | $75K | +316.7% |
| Investing Cash Flow | -$75K | -316.7% |
| Financing Cash Flow | $6.5M | -48.5% |
| Free Cash Flow | -$8.2M | -1.4% |
| -21.5% |
| EPS (Basic) | -$6.00 | +5.1% |
| EPS (Diluted) | -$6.00 | +5.1% |